Meds Coupons

View Deals

8 Coupons

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .

    humira does not improve aortic vascular inflammation in psoriasis patients .

    david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation. .

    gallery
    .